

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Histone Methyltransferase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRD4770 | ✔ | 99%+ | |||||||||||||||||
| UNC1999 |
+++
EZH1, IC50: 45 nM EZH2, IC50: 2 nM |
99%+ | |||||||||||||||||
| EPZ005687 |
++
EZH2, Ki: 24 nM |
98+% | |||||||||||||||||
| EPZ015666 |
+++
PRMT5, Ki: 5 nM |
99%+ | |||||||||||||||||
| 3-Deazaneplanocin A HCl |
++++
S-adenosylhomocysteine hydrolase, Ki: 50 pM |
99%+ | |||||||||||||||||
| Tazemetostat |
+++
EZH2, Ki: 2.5 nM EZH2, IC50: 11 nM |
98% | |||||||||||||||||
| GSK126 |
++
EZH2, IC50: 9.9 nM |
99%+ | |||||||||||||||||
| MI-3 |
+
Menin-MLL, IC50: 648 nM |
98% | |||||||||||||||||
| MM-102 |
++
MLL1, IC50: 0.4 μM |
99% | |||||||||||||||||
| EI1 |
++
EZH2 (Y641F), IC50: 13 nM Ezh2 (wild-type), IC50: 15 nM |
96% | |||||||||||||||||
| SGC0946 |
++++
DOT1L, IC50: 0.3 nM |
99%+ | |||||||||||||||||
| PFI-2 HCl |
++++
SETD7, Ki: 0.33 nM SETD7, IC50: 2 nM |
99%+ | |||||||||||||||||
| Pinometostat |
++++
DOT1L, Ki: 80 pM |
99%+ | |||||||||||||||||
| EPZ004777 |
+++
DOT1L, IC50: 0.4 nM |
99%+ | |||||||||||||||||
| Entacapone |
++
COMT, IC50: 151 nM |
95% | |||||||||||||||||
| UNC0379 |
+
SETD8, IC50: 7.9 μM |
99%+ | |||||||||||||||||
| Menin-MLL inhibitor MI-2 |
+
Menin-MLL, IC50: 446 nM |
98% | |||||||||||||||||
| GSK343 |
+++
EZH1, IC50: 240 nM EZH2, IC50: 4 nM |
99%+ | |||||||||||||||||
| BIX-01294 3HCl |
+
G9a, IC50: 2.7 μM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Gambogenic acid binds to Cys668 within the EZH2-SET domain, triggering EZH2 degradation through COOH terminus of Hsp70‐interacting protein (CHIP)‐mediated ubiquitination. |
| Concentration | Treated Time | Description | References | |
| BEAS-2B cells | 10 µM (IC50) | 24 hours | Inhibited proliferation of BEAS-2B cells | Pharmaceuticals (Basel). 2025 Mar 6;18(3):374. |
| H1650 cells | 3.8 µM (IC50) | 24 hours | Inhibited proliferation of H1650 cells | Pharmaceuticals (Basel). 2025 Mar 6;18(3):374. |
| A549 cells | 5 µM | 18 hours | Evaluate the effect of Gambogenic acid on TGFβ-induced A549 cell migration, results showed that Gambogenic acid significantly inhibited TGFβ-induced cell migration. | J Mol Cell Biol. 2024 Apr 10;15(11):mjad068. |
| HEK293T cells | 5 µM | 18 hours | Evaluate the effect of Gambogenic acid on TGFβ-induced SBE4-luc reporter activity, results showed that Gambogenic acid significantly reduced TGFβ-induced SBE4-luc activity. | J Mol Cell Biol. 2024 Apr 10;15(11):mjad068. |
| TF-1 cells | 8 µM | 24 hours | Evaluate the apoptosis and proliferation inhibitory effects of Gambogenic acid on TF-1 cells. Results showed that GNA significantly increased caspase 3/7 activity and inhibited cell proliferation. | Cancer Biol Ther. 2024 Dec 31;25(1):2427374. |
| SKM-1 cells | 6 µM | 24 hours | Evaluate the apoptosis and proliferation inhibitory effects of Gambogenic acid on SKM-1 cells. Results showed that GNA significantly increased caspase 3/7 activity and inhibited cell proliferation. | Cancer Biol Ther. 2024 Dec 31;25(1):2427374. |
| MDS-L cells | 4 µM | 24 hours | Evaluate the apoptosis and proliferation inhibitory effects of Gambogenic acid on MDS-L cells. Results showed that GNA significantly increased caspase 3/7 activity and inhibited cell proliferation. | Cancer Biol Ther. 2024 Dec 31;25(1):2427374. |
| HN-6 cells | 2 µM | 24 hours | Screening compounds to reduce EZH2 immunofluorescent signals, GNA was one of the most effective compounds | EMBO J. 2017 May 2;36(9):1243-1260. |
| HT29 cells | 0-5 µM | 24 hours | GNA significantly inhibited HT29 cell proliferation and induced apoptosis | Front Cell Dev Biol. 2021 Oct 6;9:736350. |
| HCT116 cells | 0-5 µM | 24 hours | GNA significantly inhibited HCT116 cell proliferation and induced apoptosis | Front Cell Dev Biol. 2021 Oct 6;9:736350. |
| Murine primary peritoneal macrophages | 0, 0.25, 0.5, 1.0, 1.5 µM | 24 hours | To assess the effect of GEA on LPS-induced NO production, results showed that GEA significantly inhibited LPS-induced NO production | Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):454-61. |
| THP-1 cells | 0, 0.25, 0.5, 1.0, 1.5 µM | 24 hours | To evaluate the effect of GEA on IL-1β secretion in human THP-1 cells, results showed that GEA effectively diminished IL-1β secretion | Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):454-61. |
| J774A.1 cells | 0, 0.25, 0.5, 1.0, 1.5 µM | 24 hours | To assess the cytotoxic effect of GEA, results showed that GEA at concentrations below 1.5 μM did not affect the viability of J774A.1 cells | Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):454-61. |
| HCC1833 cells | 1 µM, 2 µM | 24, 48, 72 hours | Inhibited proliferation and migration of HCC1833 cells, arrested cell cycle in G0/G1 phase, and promoted apoptosis | Pharmaceuticals (Basel). 2025 Mar 6;18(3):374. |
| A549 cells | 2 µM, 4 µM | 24, 48, 72 hours | Inhibited proliferation and migration of A549 cells, arrested cell cycle in G0/G1 phase, and promoted apoptosis | Pharmaceuticals (Basel). 2025 Mar 6;18(3):374. |
| HEK293 cells | 1.6 µM | 4 hours | To study the effect of GB on HSP90-HSF1/HSF2 interaction, results showed GB disrupts the interaction between HSP90 and HSF1/HSF2 | Cell Stress Chaperones. 2021 Sep;26(5):819-833. |
| HeLa cells | 4 µM | 4 hours | To study the effect of GB on HSF1, results showed GB induces HSF1 localization to nuclear stress bodies | Cell Stress Chaperones. 2021 Sep;26(5):819-833. |
| U2OS cells | 2.5 µM | 4.5 hours | To study the effect of GBA on HSF1 and HSF2, results showed GBA induces HSF1-dependent heat shock response | Cell Stress Chaperones. 2021 Sep;26(5):819-833. |
| MM.1S cells | 0.51 µM and 0.90 µM | 48 hours and 72 hours | To evaluate the effect of Gambogenic acid on the proliferation and apoptosis of MM.1S cells. Results showed that Gambogenic acid inhibited cell growth and induced apoptosis in a dose- and time-dependent manner. | J Cancer. 2017 Mar 7;8(5):839-851. |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley rats | Healthy male Sprague-Dawley rats | Lateral tail vein injection | 1.5 mg/kg | Single dose | Evaluate the pharmacokinetic properties of GNA-loaded PMs. The results showed that the AUC0→t value of GNA-loaded PMs was 3.94 times that of free GNA, indicating that PMs significantly improved the bioavailability of GNA. | Polymers (Basel). 2019 May 7;11(5):820 |
| BALB/c nude mice | HCC827 and HCC827ER xenograft models | Intraperitoneal injection | 10 mg/kg | Once daily for 27 days | To evaluate the inhibitory effect of GNA alone or in combination with erlotinib on tumor growth, GNA alone or in combination with erlotinib significantly suppressed tumor growth in the HCC827ER xenograft model | Cell Death Dis. 2018 Feb 15;9(3):262 |
| NOG hIL-3 GM-CSF transgenic mice | MDS-L/Akaluc cell xenograft model | Intraperitoneal injection | 16 mg/kg | Twice a week for 15 weeks | Evaluate the anti-tumor effects of Gambogenic acid in the MDS xenograft model. Results showed that GNA significantly inhibited MDS-L cell growth and prolonged the survival of mice. | Cancer Biol Ther. 2024 Dec 31;25(1):2427374. |
| BALB/c nude mice | MM.1S xenograft model | Intravenous injection | 2.0 mg/kg | Every two days for two weeks | To evaluate the antitumor effect of Gambogenic acid on MM.1S xenograft models. Results showed that Gambogenic acid significantly inhibited tumor growth and synergistically enhanced the antitumor effect with bortezomib. | J Cancer. 2017 Mar 7;8(5):839-851. |
| BALB/c nude mice | U266 xenograft model | Intravenous injection | 5 mg/kg | Every other day for two weeks | To evaluate the inhibitory effect of GNA on the growth of U266 xenograft tumors in vivo. The results showed that GNA significantly inhibited tumor growth without affecting the body weight of mice. | J Cancer. 2017 Sep 16;8(16):3278-3286 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.59mL 0.32mL 0.16mL |
7.93mL 1.59mL 0.79mL |
15.85mL 3.17mL 1.59mL |
|
| CAS号 | 173932-75-7 |
| 分子式 | C38H46O8 |
| 分子量 | 630.77 |
| SMILES Code | O=C(O)/C(C)=C\C[C@@]([C@@]12OC3=C4C(O)=C(C/C=C(C)/CCC=C(C)C)C(O)=C3CC=C(C)C)(OC(C)(C)[C@@]2([H])C5)C([C@]5([H])C=C1C4=O)=O |
| MDL No. | MFCD32173486 |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(166.46 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1